Log In
BCIQ
Print this Print this
 

Estrogen receptor (ESR1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Estrogen receptor (ESR1)

BCIQ
Print ChartPrint this
Marketed, 9 Marketed, 14 Marketed, 1 Marketed, 1 Marketed, 5 Approved, 1 Approved, 1 Registration, 1 Phase III, 2 Phase III, 1 Phase II, 1 Phase II, 4 Phase II, 2 Phase I, 1 Phase I, 2 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase IIPhase IIIRegistrationApprovedMarketed
Cancer

1

2

2

1

-

-

5

Cardiovascular

-

-

-

-

-

-

1

Diagnostic

-

-

-

-

-

-

1

Endocrine / Metabolic

-

1

4

2

1

1

14

Musculoskeletal

-

-

1

-

-

1

9




 Products Targeting Estrogen receptor (ESR1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

19

$162,451.2M

$161,137.6M

$1,358.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today